DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,036,097 | +2.0% | 56,575 | -1.3% | 0.50% | +6.9% |
| Q2 2023 | $13,754,160 | -5.0% | 57,309 | -0.3% | 0.46% | -12.6% |
| Q1 2023 | $14,481,036 | -0.6% | 57,456 | +4.6% | 0.53% | -7.5% |
| Q4 2022 | $14,574,299 | +3.8% | 54,913 | +1.0% | 0.58% | -3.8% |
| Q3 2022 | $14,038,000 | +6.1% | 54,350 | +4.2% | 0.60% | +9.5% |
| Q2 2022 | $13,228,000 | -9.7% | 52,175 | +4.5% | 0.55% | +2.8% |
| Q1 2022 | $14,648,000 | -1.3% | 49,939 | +10.7% | 0.53% | -2.0% |
| Q4 2021 | $14,844,000 | +12.4% | 45,117 | +4.0% | 0.54% | +0.2% |
| Q3 2021 | $13,212,000 | +15.9% | 43,397 | +2.2% | 0.54% | +14.1% |
| Q2 2021 | $11,396,000 | +17.3% | 42,470 | -1.6% | 0.47% | +9.0% |
| Q1 2021 | $9,716,000 | +4.6% | 43,166 | +3.2% | 0.44% | -6.5% |
| Q4 2020 | $9,293,000 | +4.6% | 41,835 | +1.4% | 0.46% | -9.2% |
| Q3 2020 | $8,881,000 | +22.8% | 41,243 | +0.8% | 0.51% | +12.3% |
| Q2 2020 | $7,233,000 | +29.6% | 40,903 | +1.5% | 0.46% | +6.3% |
| Q1 2020 | $5,580,000 | -3.6% | 40,315 | +6.9% | 0.43% | +16.3% |
| Q4 2019 | $5,789,000 | +7.5% | 37,714 | +1.1% | 0.37% | -1.9% |
| Q3 2019 | $5,387,000 | +2.2% | 37,303 | +1.2% | 0.38% | +0.3% |
| Q2 2019 | $5,270,000 | +10.0% | 36,877 | +1.6% | 0.38% | +5.9% |
| Q1 2019 | $4,789,000 | +32.6% | 36,281 | +3.6% | 0.35% | +18.8% |
| Q4 2018 | $3,612,000 | -1.0% | 35,019 | +4.3% | 0.30% | +12.0% |
| Q3 2018 | $3,647,000 | +9.3% | 33,564 | -0.8% | 0.27% | +1.5% |
| Q2 2018 | $3,337,000 | +13.7% | 33,824 | +12.8% | 0.26% | +9.2% |
| Q1 2018 | $2,936,000 | +10.3% | 29,992 | +4.6% | 0.24% | +5.7% |
| Q4 2017 | $2,662,000 | +11.2% | 28,681 | +2.8% | 0.23% | +2.3% |
| Q3 2017 | $2,393,000 | +2.4% | 27,899 | +0.7% | 0.22% | -1.8% |
| Q2 2017 | $2,337,000 | +4.0% | 27,699 | +5.4% | 0.23% | +0.4% |
| Q1 2017 | $2,247,000 | +8.3% | 26,270 | -1.4% | 0.22% | +2.3% |
| Q4 2016 | $2,074,000 | -0.4% | 26,644 | +0.3% | 0.22% | -6.8% |
| Q3 2016 | $2,082,000 | -27.1% | 26,569 | -6.1% | 0.24% | -27.6% |
| Q2 2016 | $2,857,000 | +14.1% | 28,289 | +7.2% | 0.33% | +11.3% |
| Q1 2016 | $2,503,000 | +4.5% | 26,377 | +2.3% | 0.29% | +4.3% |
| Q4 2015 | $2,395,000 | +109.2% | 25,793 | +92.0% | 0.28% | +100.7% |
| Q3 2015 | $1,145,000 | -0.4% | 13,435 | 0.0% | 0.14% | +9.4% |
| Q2 2015 | $1,150,000 | -8.7% | 13,435 | -9.4% | 0.13% | -8.6% |
| Q1 2015 | $1,260,000 | -1.4% | 14,835 | -0.5% | 0.14% | -2.1% |
| Q4 2014 | $1,278,000 | +10.6% | 14,912 | -2.0% | 0.14% | +7.5% |
| Q3 2014 | $1,155,000 | -2.7% | 15,215 | +0.8% | 0.13% | 0.0% |
| Q2 2014 | $1,187,000 | +5.3% | 15,087 | +0.4% | 0.13% | +0.8% |
| Q1 2014 | $1,127,000 | -2.8% | 15,030 | 0.0% | 0.13% | -5.7% |
| Q4 2013 | $1,160,000 | +7.4% | 15,030 | -3.5% | 0.14% | -3.4% |
| Q3 2013 | $1,080,000 | +28.0% | 15,580 | +16.9% | 0.14% | +18.9% |
| Q2 2013 | $844,000 | – | 13,330 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |